Roux-en-Y Gastric Bypass Is Associated With Hyperinsulinemia But Not Increased Maximal β-Cell Function

Area of Science:

• Metabolic Surgery
• Endocrinology
• Bariatric Procedures

Background:

• Roux-en-Y gastric bypass (RYGB) is frequently associated with postprandial hyperinsulinemia.
• The underlying mechanisms contributing to elevated insulin levels post-RYGB require further elucidation.

Purpose of the Study:

• To investigate whether increased blood insulin levels following RYGB are attributable to enhanced maximal beta-cell function.
• To compare insulin secretion dynamics in RYGB patients versus control groups.

Main Methods:

• A cross-sectional study involving RYGB patients (n=12) and matched non-surgical controls (n=10) and non-obese controls (n=8).
• Subjects underwent mixed-meal tolerance tests, intravenous glucose tolerance tests, hyperglycemic clamps, and arginine stimulation.
• Maximal insulin secretion was quantified via arginine stimulation (AinsRmax).

Main Results:

• RYGB patients showed significantly higher peak postprandial glucose and insulin levels compared to controls.
• No significant differences were observed in insulinogenic index or maximal insulin secretion (AinsRmax) between groups.
• Postprandial glucagon levels were significantly elevated in the RYGB group.

Conclusions:

• Post-RYGB hyperinsulinemia is not caused by an increase in maximal beta-cell function.
• Elevated insulin levels appear to be an appropriate physiological response to altered nutrient flow and absorption post-surgery.
• These findings highlight the complex metabolic adaptations following bariatric surgery.